| Serologic markers of previous malaria exposure and functional antibodies inhibiting parasite growth are associated with parasite kinetics following a Plasmodium falciparum … J Achan, IJ Reuling, XZ Yap, E Dabira, A Ahmad, M Cox, D Nwakanma, ... Clinical infectious diseases 70 (12), 2544-2552, 2020 | 33 | 2020 |
| Mass drug administration of ivermectin and dihydroartemisinin–piperaquine against malaria in settings with high coverage of standard control interventions: a cluster-randomised … ED Dabira, HM Soumare, B Conteh, F Ceesay, MO Ndiath, J Bradley, ... The Lancet Infectious Diseases 22 (4), 519-528, 2022 | 32 | 2022 |
| The importance of blood is infinite: conceptions of blood as life force, rumours and fear of trial participation in a Fulani village in rural Gambia S O’Neill, S Dierickx, J Okebe, E Dabira, C Gryseels, U d’Alessandro, ... PloS one 11 (8), e0160464, 2016 | 32 | 2016 |
| The gametocytocidal efficacy of different single doses of primaquine with dihydroartemisinin-piperaquine in asymptomatic parasite carriers in The Gambia: a randomized … J Okebe, T Bousema, M Affara, GL Di Tanna, E Dabira, A Gaye, ... EBioMedicine 13, 348-355, 2016 | 28 | 2016 |
| Malaria and helminth co-infections in children living in endemic countries: A systematic review with meta-analysis MO Afolabi, BM Ale, ED Dabira, SC Agbla, AL Bustinduy, JLA Ndiaye, ... PLoS neglected tropical diseases 15 (2), e0009138, 2021 | 22 | 2021 |
| Mass drug administration with high-dose ivermectin and dihydroartemisinin-piperaquine for malaria elimination in an area of low transmission with high coverage of malaria … ED Dabira, HM Soumare, SW Lindsay, B Conteh, F Ceesay, J Bradley, ... JMIR research protocols 9 (11), e20904, 2020 | 21 | 2020 |
| From informed consent to adherence: factors influencing involvement in mass drug administration with ivermectin for malaria elimination in The Gambia A Fehr, C Nieto-Sanchez, J Muela, F Jaiteh, O Ceesay, E Maneh, ... Malaria Journal 20 (1), 198, 2021 | 13 | 2021 |
| Reactive, self-administered malaria treatment against asymptomatic malaria infection: results of a cluster randomized controlled trial in The Gambia J Okebe, E Dabira, F Jaiteh, N Mohammed, J Bradley, NF Drammeh, ... Malaria journal 20 (1), 253, 2021 | 8 | 2021 |
| Involving community health workers in disease-specific interventions: perspectives from the Gambia on the impact of this approach A Preston, J Okebe, J Balen, JM Ribera, Y Masunaga, A Bah, E Dabira, ... Journal of Global Health Reports 3, 2019 | 5 | 2019 |
| Entomological impact of mass administration of ivermectin and dihydroartemisinin-piperaquine in The Gambia: a cluster-randomized controlled trial HM Soumare, ED Dabira, MM Camara, L Jadama, PM Gaye, S Kanteh, ... Parasites & vectors 15 (1), 435, 2022 | 3 | 2022 |
| Efficacy, safety and tolerability of pyronaridine-artesunate in asymptomatic malaria-infected individuals: a randomized controlled trial ED Dabira, S Hachizovu, B Conteh, A Mendy, H Nyang, B Lawal, ... Clinical Infectious Diseases 74 (2), 180-188, 2022 | 3 | 2022 |
| Efficacy and safety of pyronaridine-artesunate (PYRAMAX) for the treatment of P. falciparum uncomplicated malaria in African pregnant women (PYRAPREG): study protocol for a … M Djimde, JK Tshiongo, HM Muhindo, H Tinto, E Sevene, M Traore, ... BMJ open 13 (10), e065295, 2023 | 2 | 2023 |
| GAMETOCYTE CARRIAGE AFTER A TREATMENT WITH PRIMAQUINE COMBINED WITH DIHYDROARTEMISININ-PIPERAQUINE IN MALARIA-INFECTED, ASYMPTOMATIC INDIVIDUALS E Dabira BMJ Global Health 2 (Suppl 2), 2017 | 2 | 2017 |
| 'The importance of blood is infinite': conceptions of blood as life force and fear of trial participation in a Fulani village in the Gambia S O'Neill, S Dierickx, J Okebe, E Dabira, C Gryseels, U d'Alessandro, ... TROPICAL MEDICINE & INTERNATIONAL HEALTH 20, 360-360, 2015 | 2 | 2015 |
| Risk factors for non-participation in ivermectin and dihydroartemisinin-piperaquine mass drug administration for malaria control in the MASSIV trial C Kositz, H Vasileva, N Mohammed, J Achan, ED Dabira, U D’Alessandro, ... Malaria Journal 23 (1), 54, 2024 | | 2024 |
| Practical Guidelines for Standardised Resolution of Important Protocol Deviations in Clinical Trials Conducted in Sub-Saharan Africa A Zemsi, LJG Nekame, N Mohammed, ES Batchilly, E Dabira, SO Sillah, ... Therapeutic Innovation & Regulatory Science, 1-9, 2024 | | 2024 |
| Diverse and weakly immunogenic var gene expression facilitates malaria infection I Bhardwaj, PB Nyarko, AB Ashn, C Cohen, S Ceesay, J Achan, E Dabira, ... medRxiv, 2023.12. 27.23300577, 2024 | | 2024 |
| Perceptions and acceptability of the controlled human malaria infection (CHMI) model in The Gambia: a qualitative study ED Dabira, A Fehr, N Beloum, JP Van Geertruyden, J Achan, A Erhart, ... Scientific Reports 13 (1), 8708, 2023 | | 2023 |
| Protocol: Efficacy and safety of pyronaridine-artesunate (PYRAMAX) for the treatment of P. falciparum uncomplicated malaria in African pregnant women (PYRAPREG): study protocol … M Djimde, JK Tshiongo, HM Muhindo, H Tinto, E Sevene, M Traore, ... BMJ Open 13 (10), 2023 | | 2023 |
| Doing ‘reciprocity work’: The role of fieldworkers in a mass drug administration trial in the Gambia A Fehr, C Nieto-Sanchez, J Muela, E Manneh, D Baldeh, O Ceesay, ... Global public health 17 (12), 4116-4128, 2022 | | 2022 |
